Viridian Therapeutics, Inc.\DE (VRDN) › Shares OutstandingViridian Therapeutics, Inc.\DE (VRDN) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 02014: 3.78M2015: 709.0K2016: 833.7K2017: 22.57M2018: 30.84M2019: 2.32M2020: 4.23M2021: 23.92M2022: 41.31M2023: 53.99M2024: 80.99M2025: 101.83M101.83M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025101.83M+25.7%202480.99M+50.0%202353.99M+30.7%202241.31M+72.7%202123.92M+465.4%20204.23M+82.1%20192.32M-92.5%201830.84M+36.7%201722.57M+2606.8%2016833.7K+17.6%2015709.0K-81.3%20143.78M—20130—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share